🇺🇸 FDA
Pipeline program

Ketanest® S 25 mg/ml - Ampullen, Ketanest® S 5 mg/ml - Ampullen

NL77785.078.21

Approved small_molecule active

Quick answer

Ketanest® S 25 mg/ml - Ampullen, Ketanest® S 5 mg/ml - Ampullen for Complex regional pain syndrome is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Complex regional pain syndrome
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials